Core Scientific, Inc./tx (CORZ) FY2026 Q2 Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
Core Scientific, Inc./tx (CORZ) FY2026 Q2 Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$2.74 BLiabilities$7.68 BNon-current liabilities$4.94 BCurrent assets$2.44 BAssets$5.26 BNon-current assets$2.81 BEquity−$2.42 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSCash and cash equivalentsCustomer funding receivable and other current assetsRestricted cash, current portionDigital assetsProperty, plant and equipment, netRestricted cash, net of current portionIntangibles, netOperating lease right-of-use assetsOther noncurrent assetsWarrant liabilities, current portionAccrued expensesDeferred revenueAccounts payableOther current liabilitiesLong-term debtDeferred revenue, net of current portionWarrant liabilities, net of current portionOther noncurrent liabilitiesAdditional paid-in capitalCommon stock; $0.00001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; 319,587 and 314,231 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectivelyAccumulated deficitCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityCurrent liabilitiesCurrent liabilities$2.74 BWarrant liabilities, current portionWarrant liabilities, current portion$1.81 BLiabilitiesLiabilities$7.68 BAccrued expensesAccrued expenses$509.19 MDeferred revenueDeferred revenue$287.20 MAccounts payableAccounts payable$112.37 MOther current liabilitiesOther current liabilities$17.44 MNon-current liabilitiesNon-current liabilities$4.94 BCurrent assetsCurrent assets$2.44 BCash and cash equivalentsCash and cash equivalents$1.77 BLong-term debtLong-term debt$4.30 BAssetsAssets$5.26 BCustomer funding receivable and other current assetsCustomer funding receivable and other current assets$458.49 MRestricted cash, current portionRestricted cash, current portion$165.75 MDeferred revenue, net of current portionDeferred revenue, net of current portion$367.24 MDigital assetsDigital assets$49.68 MWarrant liabilities, net of current portionWarrant liabilities, net of current portion$163.68 MNon-current assetsNon-current assets$2.81 BProperty, plant and equipment, netProperty, plant and equipment, net$1.77 BOther noncurrent liabilitiesOther noncurrent liabilities$110.16 MRestricted cash, net of current portionRestricted cash, net of current portion$615.91 MIntangibles, netIntangibles, net$228.63 MAdditional paid-in capitalAdditional paid-in capital$3.23 BOperating lease right-of-use assetsOperating lease right-of-use assets$114.20 MOther noncurrent assetsOther noncurrent assets$80.97 MEquityEquity−$2.42 BCommon stock; $0.00001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; 319,587 and 314,231 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectivelyCommon stock$3.00 KAccumulated deficitAccumulated deficit−$5.65 B
Chart details

Core Scientific, Inc./tx (CORZ) FY2026 Q2 Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
5,257,493,000 US dollars
Current assets
2,443,644,000 US dollars
Non-current assets
2,813,849,000 US dollars
Liabilities
7,676,849,000 US dollars
Current liabilities
2,737,794,000 US dollars
Non-current liabilities
4,939,055,000 US dollars
Equity
negative 2,419,356,000 US dollars
Cash and cash equivalents
1,769,735,000 US dollars
Customer funding receivable and other current assets
458,489,000 US dollars
Restricted cash, current portion
165,745,000 US dollars
Digital assets
49,675,000 US dollars
Property, plant and equipment, net
1,774,142,000 US dollars
Restricted cash, net of current portion
615,911,000 US dollars
Intangibles, net
228,625,000 US dollars
Operating lease right-of-use assets
114,199,000 US dollars
Other noncurrent assets
80,972,000 US dollars
Warrant liabilities, current portion
1,811,587,000 US dollars
Accrued expenses
509,189,000 US dollars
Deferred revenue
287,201,000 US dollars
Accounts payable
112,374,000 US dollars
Other current liabilities
17,443,000 US dollars
Long-term debt
4,297,967,000 US dollars
Deferred revenue, net of current portion
367,242,000 US dollars
Warrant liabilities, net of current portion
163,683,000 US dollars
Other noncurrent liabilities
110,163,000 US dollars
Additional paid-in capital
3,229,842,000 US dollars
Common stock; $0.00001 par value; 10,000,000 shares authorized at June 30, 2026 and December 31, 2025; 319,587 and 314,231 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
3,000 US dollars
Preferred stock; $0.00001 par value; 2,000,000 shares authorized; none issued and outstanding at June 30, 2026 and December 31, 2025
0 US dollars
Accumulated deficit
negative 5,649,201,000 US dollars

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
Core Scientific, Inc./tx (CORZ) FY2026 Q2 Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!